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A B S T R A C T
Secondary injury following acute brain insults significantly contributes to poorer neurological outcome. The
spontaneous, recurrent occurrence of spreading depolarization events (SD) has been recognized as a potent
secondary injury mechanism in subarachnoid hemorrhage, malignant ischemic stroke and traumatic brain in-
jury. In addition, SD is the underlying mechanism of the aura symptoms of migraineurs. The susceptibility of the
nervous tissue to SD is subject to the metabolic status of the tissue, the ionic composition of the extracellular
space, and the functional status of ion pumps, voltage-gated and other cation channels, glutamate receptors and
excitatory amino acid transporters. All these mechanisms tune the excitability of the nervous tissue. Aging has
also been found to alter SD susceptibility, which appears to be highest at young adulthood, and decline over the
aging process. The lower susceptibility of the cerebral gray matter to SD in the old brain may be caused by the
age-related impairment of mechanisms implicated in ion translocations between the intra- and extracellular
compartments, glutamate signaling and surplus potassium and glutamate clearance. Even though the aging
nervous tissue is thus less able to sustain SD, the consequences of SD recurrence in the old brain have proven to
be graver, possibly leading to accelerated lesion maturation. Taken that recurrent SDs may pose an increased
burden in the aging injured brain, the benefit of therapeutic approaches to restrict SD generation and propa-
gation may be particularly relevant for elderly patients.
1. Introduction
1.1. Occurrence of spreading depolarization (SD) in neurological diseases
Spreading depolarization (SD) is a wave of massive depolarization
of a critical mass of neurons and presumably glia cells, which – together
with a concomitant depression of spontaneous brain electrical activity –
propagates across the cerebral gray matter at a low rate of 2–8mm/min
(Leao, 1944; Somjen, 2001). Not long after its discovery, SD was
speculated to correspond with scotomas of migraine with aura on the
basis of a similar rate of propagation (Milner, 1958), although no direct
proof could be gathered at the time to indisputably support the claim.
Consequently, SD was considered for decades as an experimental
curiosity, or a model for neurovascular coupling, the latter due to the
evolution of an associated, robust cerebral blood flow (CBF) response.
The CBF response to SD generally consists of an initial, brief vasocon-
striction, followed by a remarkable, transient, and then a less obvious
late hyperemia, which are succeeded by a long lasting oligemia. The
final, oligemic element of the CBF response is typically obvious in the
non-ischemic cortex in case a prior SD event was not generated within
the preceding hour. The presence and weight of each, distinct phase in
the CBF response may vary in different species, and is subject to the
metabolic state of the tissue, establishing a spectrum of CBF response
types ranging from the spectacular dominance of peak hyperemia to
ruling vasoconstriction known as spreading ischemia (Ayata and
Lauritzen, 2015).
SD in a patient – rather than in experimental model systems – was
first captured during the aura phase of a migraine attack. In fact, an
epiphenomenon, spreading oligemia was revealed by positron-emission
tomography (PET) (Lauritzen et al., 1983). Later the full CBF response
to SD (i.e. including both hyperemia and oligemia) was confirmed in
migraine patients by functional magnetic resonance imaging using
blood oxygen level detection (fMRI-BOLD) techniques (Hadjikhani
et al., 2001). The clinical evidence were highly significant, but still
https://doi.org/10.1016/j.neuint.2018.10.010
Received 7 September 2018; Received in revised form 10 October 2018; Accepted 13 October 2018
∗ Corresponding author.
E-mail addresses: hertelendy.peter@med.u-szeged.hu (P. Hertelendy), vardan.bio@gmail.com (D.P. Varga), menyhartakos89@gmail.com (Á. Menyhárt),
bari.ferenc@med.u-szeged.hu (F. Bari), farkas.eszter.1@med.u-szeged.hu (E. Farkas).
Neurochemistry International 127 (2019) 125–136
Available online 15 October 2018
0197-0186/ © 2018 Elsevier Ltd. All rights reserved.
T
indirect, since the CBF variation characteristic of SD, rather than SD
itself (the primary, electrophysiological event), was identified. Still, SD
has been justly acknowledged to accompany the aura phase of migraine
(Ayata, 2010), and the associated transient depression of neural activity
has been linked to neurological symptoms such as scintillations and
scotomas (Goadsby et al., 2017; Milner, 1958). Although it is still de-
bated, SD may sensitize the trigeminovascular system, activate me-
ningeal nociceptors, and thereby contribute to migraine headache itself,
as well (Ayata, 2009; Goadsby et al., 2017).
The first, direct indication for SD to occur in the human brain was
presented by multiparametric monitoring of the cerebral cortex of se-
vere traumatic brain injury (TBI) patients. The synchronous acquisition
of CBF, extracellular K+ concentration ([K+]e), direct-current (DC)-
potential, electrocorticogram (ECoG) and changes in NADH redox state
unequivocally confirmed that SD, in association with injury, evolves in
a recurrent fashion in the human brain (Mayevsky et al., 1996, 1998).
Subsequently, the systematic monitoring of SD in acute brain injury
patients (i.e. TBI, subarachnoid hemorrhage - SAH, malignant ischemic
stroke) took off starting with a landmark study (Strong et al., 2002).
The most reliable approach to detect SD has since become the use of
subdural surface electrode strips left in place for up to several days after
the neurosurgical intervention to alleviate the primary traumatic or
ischemic insult (Dreier et al., 2017). Because the recording of SDs with
scalp electrodes requires further validation (Hartings et al., 2014), SD
monitoring at present remains predominantly invasive, limited to acute
brain injury patients requiring craniotomy. These studies keep deli-
vering highly valuable data on the pattern of evolution and injurious
potential of SD, and promote SD as an indicator or mediator of ongoing
secondary damage (Dreier et al., 2017; Hartings et al., 2017).
1.2. Contribution of SD to lesion progression
Following SAH, delayed cerebral infarctions (DCI) (i.e. focal neu-
rological deterioration, new ischemic lesions and related neurological
symptoms) arise unpredictably, typically 5–14 days following the initial
injury. DCI was originally attributed to vasospasm in the proximal large
vessels, but, more recently, the additional contribution of micro-
thrombus formation and microvascular hypoperfusion was revealed
(Rowland et al., 2012). Microvascular hypoperfusion, in particular, was
suggested to be caused by clusters of SD (Dreier et al., 2006). Such SDs
may be coupled with inverse hemodynamic response and concomitant
tissue hypoxia, deepening the metabolic crisis of the tissue and leading
to ischemic lesion progression (Bosche et al., 2010; Dreier et al., 2009).
The inverse hemodynamic response to SD has also been observed in TBI
patients, and presented as a novel mechanism of secondary brain injury
(Hinzman et al., 2014). As further support for the injurious potential of
recurrent SDs, the high number of SDs and the total depolarization time
were closely associated with DCI development, independent of vasos-
pasm (Dreier et al., 2006; Woitzik et al., 2012).
Recently, repetitive SDs – in clusters or alone - have also been
identified in patients suffering malignant ischemic stroke (Pinczolits
et al., 2017; Woitzik et al., 2013). In focal cerebral ischemia, repetitive
SDs are thought to arise from the border of the penumbra and the is-
chemic core (Bere et al., 2014; Kao et al., 2014), probably initiated by
hypotensive or hypoxic transients (von Bornstadt et al., 2015). These
SDs may increase the chance of infarct maturation by converting viable
penumbra tissue to the core beyond repair (Hartings et al., 2017). The
coincidence between the severity of ischemic damage and SD occur-
rence was corroborated by the linear correlation between the total
depolarization time or SD frequency with infarct maturation in rodent
focal ischemia models (Back et al., 1994, 1996; Dijkhuizen et al., 1999;
Takano et al., 1996). In order to determine the direction of causality,
SDs elicited experimentally distant to ischemic foci were shown to
propagate to penumbra-like tissue and increase the size of the ischemic
infarct (Busch et al., 1996), verifying that SDs may contribute to is-
chemic lesion progression.
1.3. Age as a risk factor for neurological diseases in which SD is relevant
Taken that SD emerges as a potent mechanism of secondary brain
injury in patients, it is of great interest what conditions favor SD oc-
currence. In neurological disorders implicating SD (i.e. migraine with
aura, or acute brain injury including TBI, SAH, and malignant ischemic
stroke), age is known as an independent risk factor for the incidence
and prevalence of the disorders (Fig. 1). For example, the age-depen-
dent prevalence of migraine has been shown to be bimodal, as migraine
incidence peaks at the age of 19 and 48 years in men, and at the age of
25 and 50 in women (Victor et al., 2010) (Fig. 1). Among the general
population, TBI has a peak incidence during childhood (falls), adoles-
cence (motor-vehicle accidents) and geriatric age (falls) (Bruns and
Hauser, 2003) (Fig. 1). Further, SAH is one of the most common types
of stroke in young adults, and younger age is an established risk factor
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Fig. 1. The age-related alteration of spreading depolarization (SD) suscept-
ibility against the prevalence of neurological diseases, in which SD is implicated
as a pathophysiological phenomenon. Note, that data underscoring the mod-
ification of SD susceptibility over the lifespan are predominantly based on ex-
perimental SD elicitation. In order to compare data from clinical and experi-
mental research, the secondary x-axis represents the rat lifespan matched with
human (Sengupta, 2013). Gray area highlights the time period, over which
increased SD susceptibility coincides with the increased prevalence of neuro-
logical diseases, such as migraine, traumatic brain injury (TBI) and delayed
cerebral ischemia (DCI) following subarachnoid hemorrhage (SAH).
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for secondary lesion progression in SAH, caused by proximal large ar-
tery vasospasm (Charpentier et al., 1999; Rabb et al., 1994) and DCI
(Crobeddu et al., 2012; de Rooij et al., 2013; Magge et al., 2010)
(Fig. 1). Finally, aging significantly predicts poor patient outcomes after
ischemic stroke (Chen et al., 2010; Liu and McCullough, 2012). The
incidence and poor outcome of stroke steeply rises with age (Chen
et al., 2010) (Fig. 1). In this context, the impact of age on stroke pa-
thophysiology has been the target of intensive research in order to
understand the reason for the increased susceptibility of the aged brain
to stroke-related injury, yet the potential contribution of SD has re-
mained largely unexplored.
In recent years, outstanding and comprehensive reviews focusing on
different aspects of SD have been published: the pharmacological pro-
file of SD (Pietrobon and Moskowitz, 2014); the linkage between mi-
graine, stroke and SD (Dreier and Reiffurth, 2015); the aspects of he-
modynamic response to SD (Ayata and Lauritzen, 2015) and the pivotal
role of SD during ischemic injury (Hartings et al., 2017). Here we set
out to provide an overview on the susceptibility of the nervous tissue to
SD, with a principal focus on age.
2. Aging and the susceptibility of the nervous tissue to SD
2.1. SD triggered experimentally
The neonatal brain appears to be too immature to sustain experi-
mentally triggered SD. In the intact rat cortex, SD can be first initiated
from postnatal days 12–15 (Bures, 1957; Richter et al., 1998; Schade,
1959). The threshold of SD elicitation was thought to decrease until
adulthood, and expected to decrease further with aging, theoretically
due to the shrinkage of the extracellular space (Somjen, 2001). How-
ever, the latter view on aging appears to be superseded by accumulating
experimental evidence. First, the rate of SD propagation was shown to
decelerate in the aging rodent brain (Guedes et al., 1996). Also, in-
creasingly higher concentration of KCl was required to trigger SD in
brain slices obtained from middle-aged rats with respect to young
adults (Maslarova et al., 2011), and in the old versus young anesthe-
tized rat cerebral cortex (Menyhart et al., 2015, 2017b). Further, the
same, incessant, standard trigger (1M KCl) produced a lower number of
recurrent SDs in the middle-aged with respect to the young adult cer-
ebral cortex in anesthetized rats (Farkas et al., 2011). Finally, a more
sensitive, refined experimental approach dissected that between the
ages of 7–30 weeks of rats - corresponding to adolescence and young
adulthood in humans (Sengupta, 2013) – progressively increasing
electrical charge was necessary to elicit SD, especially when the cortex
suffered of global forebrain ischemia (Hertelendy et al., 2017). In the
non-ischemic cortex, the elevating electric threshold of SD elicitation
coincided with increasing dendritic spine density, which might outline
an association between SD threshold and the fine histological and
possibly neurochemical organization of the cortex (Hertelendy et al.,
2017).
In further support for the concept that the aged nervous tissue is less
able to sustain SD, additional experimental results may be lined up. In
the full band ECoG, SD is seen as a transient, spreading depression of
activity (Leão, 1944) – unless the ECoG is already isoelectric prior to SD
occurrence due to a severe insult (Hartings et al., 2011). The duration of
the ECoG depression in the non-ischemic rat cerebral cortex may last
for over 2min in the young, but for only half of this time duration in
middle-aged animals (Farkas et al., 2011). The shortening of the SD-
related ECoG depression appears to be evident first in the low frequency
components (delta and theta bands) at middle-age (7 months old)
(Hertelendy et al., 2017), and concerns all frequency bands at old age
(18 months old) (Makra, 2018). These data have been interpreted to
depict a narrower SD wave front in space, standing for a smaller volume
of nervous tissue involved in SD at a given point in time (Farkas et al.,
2011; Hertelendy et al., 2017; Makra, 2018).
Another read-out to be taken as an indicator for the susceptibility of
the nervous tissue to SD is the distance covered by SD before coming to
a halt. Indeed, some SD events are gradually extinguished over their
course of propagation, rather than traversing the entire cortical surface,
as demonstrated by multimodal experimental imaging studies (Bere
et al., 2014; Kaufmann et al., 2017; Menyhart et al., 2017a). Even
though not documented so far, we observed that in old (18 months old)
rats, experimentally triggered SDs are more likely to terminate after
having propagated only a few millimeters away from the site of elici-
tation than in young (2 months old) rats.
2.2. SD that occurs spontaneously in response to hypoxia/ischemia
Even though these studies consistently demonstrated that SD events
are less likely to occur or evolve fully with aging (Fig. 1), the experi-
ments relied on provoking SD experimentally (i.e. by the application of
high concentration KCl or electrical stimulation), rather than evaluating
the likelihood of spontaneous SD evolution as it takes place in acute
brain injury. The distinction between experimentally triggered and
spontaneously generating SDs may be important, because their phar-
macology is different, and thus the share of specific ion channels in
their igniting mechanisms may not be identical (Pietrobon and
Moskowitz, 2014). In addition, the share of ion channels in supporting
the generation and propagation of SD is dependent on the metabolic
conditions of tissue (Dreier and Reiffurth, 2015). This is best illustrated
by the observations that NMDA receptor antagonism effectively blocks
SD in well-nourished tissue (Marrannes et al., 1988), but fails to do so
under severe ischemic conditions (Hertle et al., 2012). Accordingly,
contemplating the age specific pattern of spontaneous SD occurrence
adds new perspectives. To begin with, the earliest age when sponta-
neous SD was shown to emerge due to asphyxia proved to be as early as
postnatal day 4 (Hansen, 1977) – in contrast with postnatal days 12–15
determined as the youngest age in which SD can be triggered experi-
mentally (Bures, 1957; Richter et al., 1998; Schade, 1959). The im-
pediment for SD to evolve in such a young brain was, however, con-
firmed by a remarkable 20min delay of SD onset with respect to
asphyxia initiation, in contrast with the 1.5min delay observed in adult
rats (Hansen, 1977) – the longer delay possibly indicating a better
tolerance of the nervous tissue against deleterious insults. Towards the
other end of the life span, the frequency of spontaneous, recurrent SDs
was, likewise, found significantly lower in the old (23–25 months old)
than in young (1.5 months old) and the middle-aged (9 months old) rat
brain in a model of focal cerebral ischemia (Clark et al., 2014). This
finding stands in agreement with the above data gathered using ex-
perimental SD initiation. The reason for the low SD frequency at old age
could not be identified with certainty, but SDs that are often long-
lasting in the old brain considerably postponed – if not altogether
prevented – the occurrence of subsequent SDs, which offered a plau-
sible explanation (Clark et al., 2014). Indeed, the duration of transient
SD triggered under ischemia appeared to be longer-lasting in the old rat
brain as compared with the young (Menyhart et al., 2015). Further, in
the focal ischemia model not only the higher incidence of long-lasting
SDs was characteristic among the old animals than in the younger ones,
but also the larger cortical surface involved in these prolonged SD
events (Clark et al., 2014). Apparently, the recovery from SD in the old
brain appears to be hampered. This may point towards or underlie the
increased vulnerability of the old brain to ischemic conditions, and the
pathophysiologic role SD is suggested to play in injury progression.
Curiously, in another study, the generation of a spontaneous SD in
immediate response to bilateral common carotid artery occlusion was
more frequently encountered in old animals than in their young
counterparts (Menyhart et al., 2017b). Reflecting on the evidence
presented here so far, this observation may seem perplexing at first, yet
it is, in fact, complementary, and makes the interpretation of existing
data more subtle. It must be appreciated that the spontaneous occur-
rence of SD in these experiments was strongly associated with a severe
drop of perfusion (to 7–23% of baseline flow), rather than with age
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itself, the serious perfusion deficit being more frequent among the old
rats (Menyhart et al., 2017b). Taken together, we postulate that irre-
spective of the age-related electrophysiological threshold of SD elici-
tation (which has proven to be higher at old age), a sudden, large drop
of cortical perfusion (i.e. blood flow plunging below 20%) will in-
evitably bring on SDs in the old brain, as well as in the young. We also
believe that even though it is more difficult to trigger SDs in the aging
brain, once SD is elicited during ischemia, it is persistent at old age, and
its long duration may indicate metabolic crisis (Farkas and Bari, 2014).
The experimental research conducted so far has thus provided
compelling evidence for the impact of age on the susceptibility of the
cerebral gray matter to SD (Fig. 1), yet clinical studies are sparse in this
regard, probably due to the inherent limitation of having to consider a
high number of risk factors other than age. Still, SDs were reported to
occur at higher incidence in young compared to older patients who
suffered acute brain injury (Fabricius et al., 2006), which observation is
in harmony with the experimental results.
In order to understand what cellular pathways may be altered to
account for the higher resistance of the old nervous tissue against SD,
the determining factors of SD occurrence will be examined next.
3. Mechanisms behind SD susceptibility
It has been inferred above that various parameters can be taken to
express SD susceptibility, such as (i) the latency of SD occurrence with
respect to the stimulus, (ii) the frequency of recurrent SD events, (iii)
the rate of SD propagation, (iv) the distance SD covers over its course of
propagation, or (v) the duration of ECoG depression. Some of these
parameters concern SD initiation (i.e. latency with respect to igniting
stimulus), others essentially characterize propagation (i.e. rate and
distance covered, duration of ECoG depression), or represent a mixture
of both initiation and propagation (i.e. frequency of recurrent SDs). The
capability of the nervous tissue to recover from SD may be a relevant
factor to consider as well, since delayed repolarization may postpone
the occurrence of subsequent SD events, and is expected to reduce SD
frequency. The network of astrocytes is thought to contribute to this
process. In addition, the buffering capacity of astrocytes may also
modulate the delay necessary to reach the neurochemical threshold of
SD elicitation. Understanding what mechanisms drive SD initiation,
propagation, and repolarization is a first step to appreciate how aging
may impact on SD susceptibility.
3.1. SD elicitation
In the healthy mammalian brain, extracellular K+ concentration is
kept close to 3–4mM, independent of fluctuations in blood serum levels
(Somjen, 1979), but local changes in extracellular K+ levels do occur
following neuronal activity. In the injured brain, the concentration of
K+ (10–15mM) sufficient to induce SD is presumably determined by
the balance between K+ efflux and the efficacy of K+ clearance (Spong
et al., 2016). In the context of spontaneous SD occurrence under hy-
poxia or ischemia, an initial outward K+ current – which is also re-
flected by the slow depolarization preceding SD (Hansen, 1977; Hansen
and Zeuthen, 1981) – may be, in part, a key trigger. This progressive
accumulation of extracellular K+ is thought to build up due to the re-
duced availability of ATP, which opens ATP-sensitive K+ channels to
hyperpolarize neurons via K+ efflux (Sun and Hu, 2010), and, more
importantly, reduces the efficiency of neuronal Na+/K+-ATPase and
thus K+ reuptake (Hajek et al., 1996). In addition, extracellular levels
of K+ typical of the ischemic penumbra were shown also to decrease
Na+/K+-ATPase activity by 50% (Major et al., 2017), therefore K+
itself may amplify its extracellular accumulation. The central role of
Na+/K+-ATPase in SD initiation is clearly supported by the fact that
tissue exposure to ouabain, a Na+/K+-ATPase inhibitor, readily pro-
duces SD (Balestrino et al., 1999). Ultimately, the excess K+ in the
extracellular space amounts to a depolarizing stimulus that, by the
gradual shift in membrane potential, opens voltage-gated Na+ channels
to give way to Na+ influx. The experimental elicitation of SD with high
concentration KCl or electrical stimulation takes advantage of the ar-
tificial elevation of extracellular K+ as well.
When a critical threshold of K+ levels is reached, the self-propa-
gating SD cycle takes off and invades neighboring tissue (Grafstein,
1956). However, the critical threshold of K+ concentration appears to
be subject to other, variable conditions such as the degree of metabolic
impairment or the maturation of the brain, and a set threshold value
that would be uniformly valid cannot be determined. To illustrate the
variability of SD threshold from the perspective of aging, the extra-
cellular concentration of K+ sufficient for the spontaneous occurrence
of SD due to asphyxia in adult rats (i.e. > 24 weeks old) ranged around
10–12mM, but was over 20mM in 12-week-old rats, and could be as
high as 30mM in 4-day-old pups (Hansen, 1977).
In migraine with aura, the progressive accumulation of K+ to high
concentration as it takes place in injured tissue is unlikely, therefore an
increased sensitivity or hyperexcitability of neurons may stand in the
center of SD elicitation (Vinogradova, 2018). In addition, hyper-
excitablity may be relevant for ischemia-related SD, as well, since
theoretically such a condition may predict SD occurrence at a lower
threshold. Neuronal excitability is partly regulated by neuronal voltage-
dependent Na+ (Nav), K+ (Kv), and Ca2+ (Cav) channels (Misonou,
2010). Structural variations, modulation by second messengers and
genetic dysfunction of these channels might influence the SD threshold,
the latter being implicated, for example, in familial hemiplegic mi-
graine (FHM) type 1 (FHM1) and 3 (FHM3) (Dichgans et al., 2005; van
den Maagdenberg et al., 2004). As such, FHM3 has been linked to a
mutation of the α1 subunit of Nav 1.1 (encoded by the SNCA1A gene),
which elicits neuronal hyperexcitability and might decrease SD
threshold (Dichgans et al., 2005). Neuronal hyperexcitability, on the
other hand, is prevented by the activation of Kv1 type delayed-rectifier
K+ channels (Hille, 1992). Interestingly, the selective pharmacological
blockade of cerebellar Kv 1.1 and Kv1.2 channels – highly expressed in
the cerebellar cortex and Purkinje-cells – was shown to decrease sig-
nificantly the threshold of spreading acidification and depression in the
cerebellar cortex, a phenomenon sharing similarities with SD (Chen
et al., 2005). Another type of Kv channel to suppress neuronal excit-
ability is the Kv7.2 (KCNQ2) ion channel (Wulff and Zhorov, 2008).
Kv7.2 agonism was found to decrease the frequency of KCl-induced SDs
in a dose-dependent manner, probably by promoting membrane hy-
perpolarization (Wu et al., 2003). Finally, a dominant-negative muta-
tion in the TWIK-related spinal cord K+ (TRESK) channel caused hy-
perexcitability in trigeminal neurons (Liu et al., 2013), and was linked
to migraine with aura (Enyedi et al., 2012), but the contribution of
TRESK channels to SD elicitation has not been demonstrated yet.
Neuronal excitability may be modulated by Cav channels as well.
FHM1 is characterized by a mutation in the CACNA1A gene encoding
the P/Q type Ca2+ channel (van den Maagdenberg et al., 2004), in-
creasing its opening probability. In mice, the gain of function mutation
was shown to lower electrical SD threshold in vivo in two different
variants, S218L and R192Q, both of which were previously shown to be
present in FHM patients. The decreased threshold of SD together with
increased neuronal excitability is probably mediated by the higher
opening probability of the channels at presynaptic terminals (Tottene
et al., 2009).
Taken together, these experimental data suggest, that voltage-gated
cation channels that tune neuronal excitability contribute to setting the
threshold of SD elicitation.
3.2. SD evolution and propagation
Irrespective of whether SD is elicited experimentally or occurs
spontaneously, the rapid and marked increase of extracellular K+ is a
powerful trigger, which depolarizes a critical volume of tissue of about
1mm3 (Matsuura and Bureš, 1971; Tang et al., 2014). The mass cellular
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depolarization leads then to a near-complete breakdown of neuronal
transmembrane potential (Somjen, 2001). More specifically, at any
point of the tissue involved in SD, the influx of Na+ leads the depo-
larization, causing a reduction of extracellular Na+ concentration from
140 to 150 to 50–70mM, accompanied by a sudden extracellular surge
of K+ from 3 to 4 to 30–60Mm, a concurrent decrease of extracellular
Ca2+ levels from 1 to 1.5 to 0.2–0.8 mM and that of Cl− from 130 to
74mM (Hansen and Zeuthen, 1981; Pietrobon and Moskowitz, 2014).
Intracellular ion concentrations obviously change in the opposite di-
rection.
The channels mediating K+ efflux during depolarization are still to
be explored, but it is reasonable to suggest that Kv channels must be
involved, because the wide spectrum K+ channel blocker tetra-
ethylammonium (a drug that acts on inward rectifying and delayed
outward rectifying K+ channels) (Cook, 1990); and 4-aminopyridine (a
blocker of inward rectifier and A-type K+ channels) partially limited
K+ efflux with SD (Aitken et al., 1991; Somjen, 2001). Recent evidence
indicates that large-conductance Ca2+-activated K+ (BK) channels
contribute to the K+ surge with SD (Menyhart et al., 2018), and ATP-
sensitive K+ channels that open under metabolic stress could also be
involved (Somjen, 2001). Finally, it is suspected that during hypoxia/
ischemia, massive nonselective Na+(Ca2+)/K+ conductances take
place with SD, via a yet unidentified channel (Czeh et al., 1992, 1993;
Gagolewicz, 2017).
Ca2+ influx with SD may take place through P/Q type Cav channels,
which was tested by the application of gabapentine, an anticonvulsant
agent, with P/Q type Ca2+ channel inhibitory potential. Gabapentin
infusion effectively suppressed SD susceptibility in the intact rat cortex
(Hoffmann et al., 2010). Likewise, the topical application of the P/Q
type Cav channel blocker ω-agatoxin was also found to remarkably
reduce the frequency of repetitive SDs (Richter et al., 2002).
In addition to the ion dislocations, interstitial glutamate con-
centration also increases from 3–3.5 to 10–11 μM with SD induced by
KCl in normal rat cortex (Hinzman et al., 2015), or well over 100 μM in
the striatum during anoxia (Satoh et al., 1999). The accumulation of
glutamate may manifest via various pathways. Considering SD trig-
gered experimentally in well-nourished tissue, the first results obtained
with mutant P/Q type Cav mice suggested that Ca2+ influx with SD
through these channels liberates glutamate and contributes to SD evo-
lution (Ayata et al., 2000; Pietrobon and Moskowitz, 2014). Glutamate
release with SD later was shown to be linked to presynaptic N-methyl-
D-aspartate (NMDA) receptor-dependent vesicular exocytosis (Zhou
et al., 2013). Further, SD has been found to open neuronal pannexin-1
channels (Karatas et al., 2013) that may also mediate the release of
glutamate to some extent (Cervetto et al., 2013; Di Cesare Mannelli
et al., 2015). Conversely, the pharmacologic inhibition of the P2X7-
pannexin-1pore complex suppressed SD, which was suggested to alle-
viate the release of K+, glutamate and pro-inflammatory cytokines
(Chen et al., 2017). Glutamate may also originate from astrocytes
through pathological processes, including the possibility that increased
extracellular K+ concentration reverses excitatory amino acid trans-
porters (EAATs) (Harada et al., 2015; Malarkey and Parpura, 2008;
Nicholls and Attwell, 1990).
Once glutamate builds up to high concentrations, it may over-
stimulate NMDA receptors, thereby deepening the depolarization, and
contributing to SD propagation by the further accumulation of K+ and
glutamate (Harreveld, 1959). Although the NMDA receptor is con-
sidered the primary glutamate receptor involved in SD facilitation,
some recent studies indicate the role of α-amino-3-hydroxy-5-methyl-4-
isoxazole propionate (AMPA) receptors (Costa et al., 2013) and extra-
synaptic NMDA receptors (Hardingham and Bading, 2010) as well.
Furthermore, recent investigations have suggested the specific in-
volvement of NMDA receptor subtypes NR2A and NR2B in SD sus-
ceptibility (Shatillo et al., 2015; Wang et al., 2012). The involvement of
the NMDA receptor in the sustenance of SD is underscored by influ-
ential clinical studies disclosing that the administration of ketamine, an
NMDA receptor antagonist to patients of acute brain injury inhibits SD
occurrence effectively (Carlson et al., 2018; Sakowitz et al., 2009). Fi-
nally, the volatile anesthetics isoflurane and N2O, which also dampen
NMDA receptor-based excitatory neurotransmission, were shown to
suppress SD susceptibility in rats (Kudo et al., 2008). It must be noted,
however, that SD evolving in response to anoxia/ischemia cannot be
blocked by NMDA receptor antagonism, suggesting the negligible in-
volvement of NMDA receptors in SD propagation under severe meta-
bolic stress (Pietrobon and Moskowitz, 2014).
The volume of the extracellular space also adjusts the concentration
of substances present in the extracellular fluid. Water passively follows
the fluxes of Na+ and especially Cl− via Cl−-coupled transporters
(Steffensen et al., 2015) to cause swelling of dendrites (termed “den-
dritic beading”) and astrocytes (Risher et al., 2012), with a concomitant
shrinkage of the extracellular space. This may increase the concentra-
tions of extracellular K+ and glutamate even further (Hansen and
Olsen, 1980; Phillips and Nicholson, 1979).
All these results testify that once SD has been elicited, the levels of
K+ and glutamate, which facilitate SD, progressively rise. The propa-
gation of SD, therefore, is thought to be self-sustained, advocated by the
volume transmission of high concentration K+ and glutamate generated
by SD itself.
3.3. Recovery from SD
SD is a transient event – although its duration depends on the actual
tissue metabolic conditions. The repolarization phase of SD, or recovery
of the tissue from SD is mediated by neuronal Na+/K+-ATPase to serve
K+ reuptake (Major et al., 2017). Importantly, surplus K+ is also re-
moved effectively by astrocytes, utilizing various mechanisms in-
cluding, for instance, astrocytic Na+/K+-ATPase, and K+ siphoning via
Kir 4.1 inwardly rectifying K+ channels or water flux mediated through
aquaporin-4 channels (Leis et al., 2005). Similar to K+ clearance, glu-
tamate buffering is an equally important factor in SD evolution. Glu-
tamate clearance is mainly mediated by excitatory amino acid trans-
porters 1 and 2 (EAAT1 and EAAT2), which are ion- and voltage-
dependent, predisposing glutamate reuptake highly susceptible to
changes in the ionic composition of the cellular environment and
transmembrane potential. For example, EAAT2 is not only co-localized
with Na+/K+-ATPase, but is also highly dependent on the ion gradient
it generates (Cholet et al., 2002). Among EAAT subtypes, the glial
specific EAAT2 appears to be responsible for more than 90% of gluta-
mate reuptake in the forebrain (Rimmele and Rosenberg, 2016). The
effective involvement of astrocytic buffering in SD management was
proven by deleting aquaporin-4 channels, or hindering glutamate
clearance. As such, the genetic knock-out of aquaporin-4 channels in
mice decreased the rate of the K+ surge and K+ reuptake with SD, in
association with a slower rate of SD propagation, and lower SD fre-
quency (Yao et al., 2015). On the other hand, EAAT2-mediated gluta-
mate clearance hampered in the absence of the α2 subunit of the as-
trocytic Na+/K+ ATPase was associated with the facilitation of SD
initiation (Capuani et al., 2016). Moreover, mice carrying the genetic
knock-in of an astrocytic Na+/K+ ATPase α2 subunit loss-of-function
mutation – as it occurs in FHM2 patients – were prone to decreased SD
threshold and increased rate of SD propagation (Leo et al., 2011).
Conversely, ceftriaxone, one of the β-lactam antibiotics, stimulated the
expression of EAAT2 in astrocytes and concurrently raised SD threshold
in FHM2 mutant mice, while inhibition of EAAT2 in wild type mice
lowered SD threshold (Capuani et al., 2016). These results collectively
suggest that EAAT2 – in tight coupling with Na+/K+ ATPase – is es-
sential for glutamate clearance by astrocytes with SD.
The capacity of astrocytes to remove excessive K+ and glutamate
might be enhanced by spatial dispersion via the astrocyte syncytium,
shown to be effective during physiological neuronal activation (Kofuji
and Newman, 2004; Pannasch and Rouach, 2013). Astrocytes (among
other cell types) are linked by gap-junctions formed by two
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hemichannels, which consist of pore forming proteins termed con-
nexins. Gap junctions are permeable to small molecules, ions and
second messengers, and serve as the structural basis for gliotransmis-
sion (Rovegno and Saez, 2018). Gap junctions might be assembled of
different connexin isoforms, which determines the role and expression
pattern of the pore, placing connexins in the position of indicating in-
tercellular communication. The exact role of connexins in SD initiation
and propagation has yet to be explored (Rovegno and Saez, 2018), but
the hypothesis may be formulated that the inter-astrocytic movement or
redistribution of ions and messengers may facilitate ion or glutamate
removal, and thus reduce SD susceptibility. In contrast with this view,
exposure to non-specific connexin inhibitors (halothane, octanol and
heptanol) blocked SD initiation in the isolated chicken retina
(Nedergaard et al., 1995), suggesting that connexin-based channels
may enable the intercellular diffusion of ions, and support the propa-
gation of SD. However, much of the work that focused on the in-
volvement of connexins in SD evolution must be interpreted with
caution, because the non-selective inhibition of connexins probably
impaired inter-neuronal in addition to astrocyte network communica-
tion. Also, apart from gap junctions, connexins form unpaired hemi-
channels, which are large and non-specific pores at the intra- and ex-
tracellular interface. Their contribution is often not discriminated at
data interpretation (Rovegno and Saez, 2018).
Among the numerous connexin isoforms, connexin-43 has emerged
as a constituent of astrocyte gap junctions. Focusing on the glial syn-
cytium alone, the genetic inactivation of connexin-43 selective for as-
trocytes markedly reduced astrocyte network communication, and in-
creased the rate of SD propagation in the hippocampus of adult mice
(Theis et al., 2003). This refined approach does support the hypothesis
posited above, confirming the ability of intact astrocyte network func-
tion to keep SD in check.
A recent study also revealed that tonabersat, a migraine prophy-
lactic drug that inhibits SD (Goadsby et al., 2009) does not only mod-
ulate neuron-satellite glia signaling in the trigeminal ganglion by acting
on connexin-26 (Damodaram et al., 2009), but also blocks connexin-43
hemichannels in isolated human cerebral microvascular endothelial
cells during simulated ischemia (Kim et al., 2017). The collective evi-
dence that a connexin-43 hemichannel blocker drug inhibits SD may be
contradictory to the finding that connexin-43 deletion in astrocytes
facilitates SD, but again, the disparity of model systems (i.e. intact
mouse brain vs. endothelial cell culture under simulated ischemia; gap
junction vs. hemichannel) may render the satisfactory integration of the
existing data challenging.
4. The impact of aging on the mechanisms involved in SD
evolution
4.1. The impact of aging on SD elicitation
The aging brain appears to be increasingly resistant to SD initiation,
as indicated by the higher threshold of experimental SD elicitation
(Hertelendy et al., 2017; Maslarova et al., 2011; Menyhart et al., 2015).
Less is known about the generation of spontaneous SDs, so – aware of
the limitations – we infer here that data obtained with experimental SD
initiation – whether in the intact or the ischemic gray matter – also
applies for spontaneous SDs. The reasons behind the increased
threshold of SD elicitation at old age may be manifold. It is conceivable
that the stimulus applied is dissipated in the tissue before SD is ignited.
Some evidence suggest that the excitability of the aged nervous tissue is
lower, because the age-specific increase in the production of reactive
oxygen species modifies the operation of the redox-sensitive K+ chan-
nels (Sesti, 2016) (Fig. 2B). This process may modulate the oligomer
formation, permeation and gating properties of Kv channels and BK
channels (Sesti, 2016), but it remains to be explored whether these
changes manifest at the level of SD evolution. Age may also hamper the
recruitment of the minimum tissue volume required for SD initiation.
Indeed, the wave front of SD in the old cerebral cortex appears to be
narrower than in the young, as seen in imaging studies, and possibly
reflected by the shorter transient ECoG depression typical of SD (Farkas
et al., 2011; Hertelendy et al., 2017; Makra, 2018).
4.2. The impact of aging on SD evolution and propagation
In addition to the age-related modification of Kv and BK channel
function mentioned above (Sesti, 2016), P/Q type Cav channels im-
plicated in SD evolution were shown to be affected by aging, as well.
Protein levels of P/Q type Cav channels in synaptosomes extracted from
the cerebral cortex significantly decreased at preserved synaptic density
Fig. 2. Conceivable targets of aging, implicated in
the susceptibility of the nervous tissue to spreading
depolarization (SD). A, Schematic illustration of the
cellular elements hosting ion channels and trans-
porters that are involved in SD evolution. B, Age-
related dysfunction of the Na+/K+ ATPase may
contribute to K+ accumulation in the interstitial
space to trigger SD. While little is certain about the
impact of aging on voltage-gated Na+ channels
(Nav), the augmented production of reactive oxygen
species with aging may alter voltage-gated K+
channel (Kv) function to reduce the excitability of
the nervous tissue (Sesti et al., 2016). Finally, aging
may suppress the expression of P/Q type voltage-
gated Ca2+ channels (Cav) (Iwamoto et al., 2004)
that may increase SD threshold. C, The age-related
downregulation of NMDA receptor subunits im-
plicated in SD (Kumar et al., 2015; Shatillo et al.,
2015; Wang et al., 2012) may impair NMDA-based
glutamate (Glu) signaling and SD propagation. Po-
tassium reuptake may be also hampered by the ac-
tivity of the Na+/K+ ATPase decreased in the aging
brain (Benzi et al., 1994; Chakraborty et al., 2003;
Cohadon and Desbordes, 1986; de Lores Arnaiz and Ordieres, 2014; Kocak et al., 2002). D, Clearance mechanisms linked to astrocytes, such as Na+/K+ ATPase
activity, the expression of excitatory amino acid transporters (EAAT) and K+ syphoning through Kir4.1 channels may become ineffective or lower in the aging brain,
leaving higher concentration of K+ and glutamate in the extracellular space, and thereby delaying repolarization. E, The spatial buffering capacity of astrocytes
complementing clearance mechanisms may also be altered by age, although direct evidence in support of the suggestion is still to be acquired. Note, that the concept
put forward here is not meant to be comprehensive, and may provoke further thoughts.
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in old rats compared to adults (Iwamoto et al., 2004). Since the phar-
macological inhibition of P/Q type Cav channels was shown to suppress
SD occurrence (Richter et al., 2002; Hoffmann et al., 2010), the de-
creased expression of the channel protein at old age may also impede
SD evolution (Fig. 2B).
The ionic movements underlying SD are also accompanied by the
release of glutamate, which sustains SD by binding to and activating
NMDA receptors. The decay of NMDA receptor-based signaling with
aging has been repeatedly demonstrated in the context of suboptimal
synaptic neurotransmission and failing cognitive performance (Kumar,
2015). It is plausible that NMDA receptor-based signaling is compro-
mised due to oxidative stress mounting to levels relevant for functional
deterioration in the aged brain. Declining NMDA receptor function was,
for example, linked to the oxidation of Ca2+/calmodulin-dependent
protein kinase II (Bodhinathan et al., 2010). Among a number of po-
tential mechanisms that may affect NMDA receptors in aging, the ex-
pression of distinct NMDA receptor subunits was found to be subject to
age-related changes, as well (Kumar, 2015). Importantly, mRNA and
protein expression of the modulatory NR2A and the NR2B subunits,
both implicated in SD evolution (Shatillo et al., 2015; Wang et al.,
2012), appeared to be downregulated in the aged brain (Kumar, 2015;
Magnusson et al., 2010; Zhao et al., 2009). In summary, the age-related
dysfunction of NMDA receptors may restrict SD evolution (Fig. 2C).
4.3. The impact of aging on the recovery from SD
The proper function of neuronal and astrocytic Na+/K+ ATPase,
and K+ and glutamate clearance mechanisms of astrocytes significantly
contribute to the cessation of SD (Leis et al., 2005; Major et al., 2017),
which is hampered in the old ischemic brain with respect to the young
(Clark et al., 2014; Menyhart et al., 2015).
Most studies conducted in this regard agree that the activity of the
Na+/K+-ATPase decreases in the aging brain (Benzi et al., 1994;
Chakraborty et al., 2003; Cohadon and Desbordes, 1986; de Lores
Arnaiz and Ordieres, 2014; Kocak et al., 2002). Crude miscrosomal
preparations must have provided evidence for the combined weakening
of neuronal and astrocytic Na+/K+-ATPase activity, because this ap-
proach is not expected to discriminate between cell types (Kocak et al.,
2002). On the other hand, investigations using synaptosomes demon-
strated the age-related decline in neuronal Na+/K+-ATPase activity,
selectively (Benzi et al., 1994; Chakraborty et al., 2003). Moreover,
enzyme activity decreasing with age has been linked to oxidative stress,
which is enhanced in the aged brain (Chakraborty et al., 2003). It is
noteworthy that Na+/K+-ATPase hyperactivity in response to ischemia
is less obvious in the aging than in the adult brain (Villa et al., 2002), in
agreement with the slower recovery from SD reported in old rats suf-
fering from cerebral ischemia (Clark et al., 2014; Menyhart et al.,
2015).
Apparently, astrocytes in the aged brain display morphological al-
terations as well as functional adaptation (Verkhratsky et al., 2016),
and show characteristics of senescence-associated secretory phenotype
(Salminen et al., 2011). Intuitively, age-related loss of function should
include the reduction of the efficacy of astrocyte transport mechanisms,
but there is only few and indirect or conflicting evidence to be lined up.
As such, both transcript and protein levels of the Kir4.1 channel and the
EAAT2 glutamate transporter were shown to be gradually down-
regulated in the pericontusional cortical region over 3 days after ex-
perimental TBI in mice, which proved to be more pronounced in the old
group of animals with respect to adults (Gupta and Prasad, 2013). Yet,
in the uninjured cortex of the same mice, aging itself increased Kir4.1
and aquaporin-4 transcript and protein levels, interpreted as an adap-
tive response to maintain K+ and water homeostasis (Gupta and
Kanungo, 2013). Further, aquaporin-4 channels participating in astro-
cytic K+ uptake appeared to be less polarized (i.e. more dispersed) in
astrocyte end feet in old mice (Kress et al., 2014). The expression of
glial fibrillary acidic protein (GFAP) increases with age (Salminen et al.,
2011), and the expression of EAAT2 has been found to decrease with
increasing GFAP content, at least in brain samples of Alzheimer's dis-
ease patients (Simpson et al., 2010). It is also intriguing that the am-
plitude of Ca2+ signaling in astrocytes in response to the activation of
their NMDA receptors was found markedly decreased at old age in
protoplasmic cells isolated from the rodent cortex (Lalo et al., 2011),
which may indicate that aging astrocytes are less responsive to gluta-
mate. Altogether, these data are suggestive that transport and signaling
by astrocytes are altered in the old brain (Fig. 2D and E). Yet it remains
to be investigated to what degree astrocyte aging contributes to the
recovery from SD, delayed in the old cerebral gray matter, especially
under ischemic conditions.
Finally, astrocyte network function that relies on gap junctional
contacts between adjacent cells may be subject to aging. Even though
the level of the most typical astrocytic gap junction protein connexin-43
seems to be maintained into old age in the rodent brain and retina, the
number, size and connexin composition of astrocytic gap junction
plaques may change (Cotrina et al., 2001; Mansour et al., 2013).
Whether these subtle but detectable alterations in gap junction struc-
ture contribute to any (mal)adaptation of astrocyte network commu-
nication with aging is yet to be examined.
5. Additional factors that modulate SD susceptibility: relevance
for brain injury
5.1. Metabolic status of the tissue
The metabolic status of the tissue has already been alluded to in the
previous chapters as an important factor to modulate SD evolution, but
its distinct aspects have not been discussed so far. The supply of glucose
and oxygen are crucial for the proper working of energy-dependent ion
pumps, and thus the effective maintenance of resting membrane po-
tential. The first indication that the restricted availability of energy
substrates facilitates, while surplus glucose impedes SD was delivered
by creating systemic hypo- and hyperglycemia in rats. Hypoglycemia
shortened, while hyperglycemia postponed the onset delay of SD in
response to hypoxia initiation (Hansen, 1978). Later, hyperglycemia
was also shown to elevate the electric threshold of SD elicitation, and to
reduce the frequency of high K+-induced recurrent SDs in normally-
perfused tissue (Hoffmann et al., 2013). Hypoglycemia, on the other
hand, did not alter SD susceptibility, but prolonged the cumulative
duration of recurrent SDs elicited in the otherwise intact cortex
(Hoffmann et al., 2013). Interestingly, suppression of glycogen, lactate
or glucose utilization in the cerebral cortex of mice reduce SD elicita-
tion threshold, suggesting a significant role for astrocyte-neuron lactate
shuttle during SD (Kilic et al., 2018). In conclusion, the unlimited
supply of circulating plasma glucose may restrict the repeated occur-
rence of SD in the intact and ischemic cerebral cortex.
While hyperglycemia thus appeared to suppress SD, hyperoxia did
not affect the duration of SD, neither did hypoxia in anesthetized,
normotensive rats (Sukhotinsky et al., 2010). Yet, in a model of focal
cerebral ischemia, episodic hypoxia or sensory stimulation causing
neural activation was associated with the elicitation of spontaneous SDs
in the somatosensory cortex (von Bornstadt et al., 2015). The me-
chanisms suggested to be involved include a worsening mismatch be-
tween increasing O2 demand against a reduced O2 supply in ischemic
penumbra tissue (von Bornstadt et al., 2015).
Anaerobic metabolism in ischemic tissue produces lactic acidosis
(Katsura et al., 1991), which is considerably augmented by SDs emer-
ging (Menyhart et al., 2017b; Selman et al., 2004). It has been long
appreciated that mild tissue acidosis suppresses SD, because pH
6.67–6.97, achieved by HCl or NaOH application, the elevation of pCO2
or withdrawal of bicarbonate in the medium of brain slice preparations
inhibited SD initiation and reduced the velocity of SD propagation
(Tombaugh and Somjen, 1996; Tong and Chesler, 2000). Low pH may
restrict SD evolution via NMDA receptor inhibition (Tang et al., 1990)
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or by the adjustment of the conductance and gating properties of Kv,
Nav, and Cav channels (Tombaugh and Somjen, 1996). Recent analysis
has refined the view that acidosis impedes SD by presenting that lower
tissue pH predicted smaller SD amplitude in the normally perfused
cerebral cortex only, while the positive correlation between tissue pH
and SD amplitude was lost under ischemia in anesthetized rats
(Menyhart et al., 2017a). In the ischemic tissue, the SD suppressing
effect of tissue acidosis was proposed to be obscured by glutamate and
K+, present at high concentration.
5.2. Neuroinflammation
Neuroinflammation has been recognized as a central pathogenic
component of cerebral ischemia. Microglia, the resident immune cells
of the brain are heavily implicated in mediating the inflammatory re-
sponse. SD is known to activate microglia (Shibata and Suzuki, 2017),
and evidence has also been accumulating recently that activated mi-
croglia may, in turn, promote SD generation. Of note, the selective
elimination of microglia was found to elevate SD threshold in brain
slices (Pusic et al., 2014), and to reduce the incidence of spontaneous
SDs in mice subjected to focal cerebral ischemia (Szalay et al., 2016).
Particularly, the M1 polarization of microglia may contribute to SD
initiation (Pusic et al., 2014). Activated microglia are the source of pro-
inflammatory cytokines such as tumor necrosis factor-α (TNFα) and
interleukin-1β (IL-1β), which may mediate the microglia-related po-
tentiation of SD. Experimental data addressing the role of TNFα in SD
susceptibility remain, however, inconclusive. Exposing brain slices to
TNFα for 3 days prior to SD elicitation decreased the threshold of SD
(Grinberg et al., 2013), yet the acute, topical administration of TNFα on
the cortical surface of anesthetized rodents reduced SD amplitude,
probably by augmenting GABA release via the activation of TNFα re-
ceptor type-2 (Richter et al., 2014). The action of IL-1β in a similar
experimental setting was found dose dependent, as only the lower dose
used attenuated SD amplitude (Richter et al., 2017). Microglia-derived
cytokines may, therefore, modulate SD susceptibility in various, com-
plex ways, which deserve further examination.
5.3. Nitric oxide
Acute cerebral ischemia gives rise to nitric oxide (NO) production,
partially in response to the release of pro-inflammatory cytokines
(Willmot et al., 2005; Murphy and Gibson, 2007). While NO produced
by the neuronal and inducible isoforms of nitric oxide synthase (nNOS
and iNOS, respectively) were shown to be neurotoxic (Huang et al.,
1994; Zhao et al., 2000), NO from endothelial source (eNOS) may be
protective against injury (Huang et al., 1996). From the perspective of
SD susceptibility, the non-selective pharmacological blockade of NOS
lowered SD threshold (Petzold et al., 2008), while the selective in-
hibition of nNOS did not significantly alter SD initiation (Petzold et al.,
2008; Urenjak and Obrenovitch, 2000). Complementary experiments
relying on the use of eNOS or nNOS knock-out mice revealed that
particularly eNOS-derived NO upheld the physiological threshold of SD
elicitation. The availability of NO from an endothelial source may,
therefore, fine-tune the susceptibility of injured tissue to SD.
All these data attest that the network of pathways that are capable
of the modulation of SD susceptibility intersect and are rather complex.
Obviously, a therapeutical approach to lessen SD occurrence in patients
may be most effective if a number of SD suppressing approaches were to
be combined and tailored to the unique conditions of specific groups of
patients.
6. Conclusions
The last fifteen years witnessed a rapid advance in our under-
standing of the pathophysiologic role SD plays in migraine with aura
(Goadsby et al., 2017), and particularly in the progression of secondary
lesions in acute brain injury (Dreier et al., 2017; Hartings et al., 2017).
Recurrent SDs evolving from minutes up to weeks following the pri-
mary insult have been recognized to contribute to the growth of sec-
ondary injury of ischemic nature, and worsen clinical outcome of
neurological conditions.
Even though aging may reduce the susceptibility of the nervous
tissue to SD (Clark et al., 2014; Farkas et al., 2011; Hertelendy et al.,
2017; Maslarova et al., 2011; Menyhart et al., 2015), the consequences
of SD recurrence in the old brain have proven to be graver (Farkas and
Bari, 2014). For example, tissue acidosis implicated in ischemic neu-
rodegeneration is associated with SD, and is disproportionately more
pronounced in the old brain than in the young (Menyhart et al., 2017a,
2017b). The cerebral blood flow response to SD may turn into dele-
terious spreading ischemia in the injured tissue (Dreier, 2011), which is
more probable in the aged cerebral cortex than in the young (Clark
et al., 2014; Menyhart et al., 2015). In fact, SDs coupled with spreading
ischemia appear to cause an overall reduction of cerebral blood flow in
the old brain, over a period when partial flow compensation should
take place (Clark et al., 2014; Menyhart et al., 2015). Finally, prolonged
SD indicative of scarcer metabolic resources of the tissue covers larger
tissue volume in the old as compared with the young cerebral cortex in
experimental focal ischemia (Clark et al., 2014). All these results un-
derscore the augmented pathogenic potential of SD in the aging brain.
The suppression of recurrent SDs or counteracting SD associated
spreading ischemia is a realistic approach for neuroprotection, and is
expected to be beneficial for injury outcome after SAH, malignant is-
chemic stroke or TBI. A number of experimental studies conducted to
this end have presented evidence that NMDA receptor blockade
(Sanchez-Porras et al., 2015; Reinhart and Shuttleworth, 2018), or the
inhibition of P/Q type Ca2+ channels potentially reduces SD suscept-
ibility (Hoffmann et al., 2010). On the other hand, L-type voltage-gated
Ca2+ channel antagonism was shown to reverse spreading ischemia to
hyperemia (Dreier et al., 1998), and lessen the weight of early hypo-
perfusion in the full cerebral blood flow response to SD (Menyhart
et al., 2018). The first clinical trials to prevent repeated SD occurrence
by the application of ketamine are promising (Carlson et al., 2018;
Sakowitz et al., 2009). Taken that recurrent SDs may pose an increased
burden in the aging injured brain, the benefit of therapeutic approaches
to restrict SD generation and propagation may be particularly relevant
for elderly patients.
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